Assessments

Pharmaceutical Trade Remains Resilient in the Face of COVID-19

Greg Priddy
Director, Global Energy and Middle East, Stratfor
Apr 8, 2020 | 10:00 GMT
A photo of pill packets. The COVID-19 pandemic has raised serious concerns about the extremely high concentration of global pharmaceutical supply chains sourced from China and India.

A photo of pill packets. The COVID-19 pandemic has raised serious concerns about the extremely high concentration of global pharmaceutical supply chains sourced from China and India.

(Shutterfly/Nenov Brothers Images)

The United States and many other countries are heavily dependent on supplies of pharmaceuticals and precursor chemicals from China and India. Widespread shortages resulting from the COVID-19 outbreak remain unlikely. Legislative proposals in the United States to force companies to "reshore" supply chains will likely falter on the increase in costs...

Article Search

Copyright © Stratfor Enterprises, LLC. All rights reserved.

Stratfor Worldview

OUR COMMITMENT

To empower members to confidently understand and navigate a continuously changing and complex global environment.

GET THE MOBILE APPGoogle Play